Calumet Inc.

Calumet delivered a major Q3 beat, with EPS of $2.91 and EBITDA of $347M, driven by Specialty Products' strength. CLMT's Specialty Products segment benefits from constrained global paraffinic base oil supply, with demand remaining inelastic and volumes above 20,000 bpd. Montana Renewables is ramping capacity, with a cleaner capital structure post-Warburg deal, supporting future sale or continued operation optionality.

Calumet, Inc. (CLMT) Q3 2026 Earnings Call Transcript

Calumet NASDAQ: CLMT reported $347 million in third-quarter adjusted EBITDA with tax attributes, as tight specialty products supplies and a strong quarter at Montana Renewables helped the company accelerate debt repayment.

Tech is snapping back after a brutal week while blue chips slip, and everyone is watching the clock for 2 p.m. ET. Will the Fed's statement keep the bounce alive, or erase it before the close?